Renalytix Investor Relations Material
Latest events
Q2 2025
Renalytix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Renalytix Plc
Access all reports
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company's lead product candidate is KidneyIntelX, a non-invasive blood test to predict the risk of rapid decline in kidney function, progression to kidney failure, and comorbidities related to Chronic Kidney Disease (CKD), including acute kidney injury, cardiovascular disease, and anemia.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
RENX
Country
🇬🇧 United Kingdom